Reference
Muller D, et al. Economic modeling of risk-adapted screen-and-treat strategies in women at high risk for breast or ovarian cancer European Journal of Health Economics : 21 Feb 2019. Available from: URL: https://doi.org/10.1007/s10198-019-01038-1
Rights and permissions
About this article
Cite this article
Testing for BRCA1/2 mutations cost effective in high-risk women. PharmacoEcon Outcomes News 823, 29 (2019). https://doi.org/10.1007/s40274-019-5719-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-019-5719-7